22.95
price down icon3.45%   -0.82
after-market Dopo l'orario di chiusura: 22.95
loading

Septerna Inc Borsa (SEPN) Ultime notizie

pulisher
Nov 05, 2024

RA Capital Management's Strategic Investment in Septerna Inc - GuruFocus.com

Nov 05, 2024
pulisher
Nov 03, 2024

Buffett Still Building This Stake, Plus Huge Insider Buy in Biotech IPO - 24/7 Wall St.

Nov 03, 2024
pulisher
Oct 31, 2024

Nasdaq debutante Septerna swells its IPO to $331m - pharmaphorum

Oct 31, 2024
pulisher
Oct 31, 2024

Septerna (NASDAQ:SEPN) Files Amendment and Restatement of Certificate of Incorporation and Bylaws - Defense World

Oct 31, 2024
pulisher
Oct 30, 2024

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering - ForexTV.com

Oct 30, 2024
pulisher
Oct 30, 2024

Ra Capital Management buys $75 million in Septerna stock - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Ra Capital Management buys $75 million in Septerna stock By Investing.com - Investing.com UK

Oct 30, 2024
pulisher
Oct 30, 2024

IPO Radar: Septerna, Swiggy and Horizon Robotics - The Armchair Trader

Oct 30, 2024
pulisher
Oct 28, 2024

Septerna sees $11.7 million in stock purchases by Third Rock Ventures - Investing.com South Africa

Oct 28, 2024
pulisher
Oct 28, 2024

IPO Roundup: Brazil Potash, Septerna and more (NYSEARCA:IPO) - Seeking Alpha

Oct 28, 2024
pulisher
Oct 26, 2024

Septerna proposes terms for upsized $175M IPO - MSN

Oct 26, 2024
pulisher
Oct 26, 2024

U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names - Seeking Alpha

Oct 26, 2024
pulisher
Oct 25, 2024

Septerna’s GPCRs draw strong demand in $288M IPO - BioCentury

Oct 25, 2024
pulisher
Oct 25, 2024

Finance Watch: Septerna Raises $288m In Public Market Debut - Citeline News & Insights

Oct 25, 2024
pulisher
Oct 25, 2024

Hedge Funds, Asset Managers Turn Dollar Bulls on Election Risks - Yahoo Finance

Oct 25, 2024
pulisher
Oct 25, 2024

Septerna Shares Jump 19% After IPO Shows Biotech Still Hot - Bloomberg

Oct 25, 2024
pulisher
Oct 25, 2024

Septerna Shares Rise 29% on First Trading Day - MarketWatch

Oct 25, 2024
pulisher
Oct 25, 2024

Septerna’s Upsized IPO Brings In $288M to Support a Pipeline of GPCR Drugs - MedCity News

Oct 25, 2024
pulisher
Oct 25, 2024

Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut - KFGO

Oct 25, 2024
pulisher
Oct 25, 2024

Septerna Shares Jump 42% After IPO Shows Biotech Still Hot - AllSides

Oct 25, 2024
pulisher
Oct 25, 2024

Goodwin, Cooley Guide Septerna's Upsized $288M IPO - Law360

Oct 25, 2024
pulisher
Oct 25, 2024

Septerna's $288M IPO is another sign of the market warming to biotech investment - Fierce Biotech

Oct 25, 2024
pulisher
Oct 25, 2024

Septerna Rings the Opening Bell - Nasdaq

Oct 25, 2024
pulisher
Oct 25, 2024

MicroStrategy Touches New Highs as Trading Volume Relative to Nvidia Surges - Yahoo Finance

Oct 25, 2024
pulisher
Oct 25, 2024

Septerna Prices Upsized 16M Share IPO at $18/sh By Investing.com - Investing.com Nigeria

Oct 25, 2024
pulisher
Oct 25, 2024

Septerna Prices Upsized 16M Share IPO at $18/sh - Investing.com

Oct 25, 2024
pulisher
Oct 25, 2024

Septerna Shares Set for Trading Debut After Upsized IPO - MarketWatch

Oct 25, 2024
pulisher
Oct 25, 2024

Goldman-backed drug developer Septerna raises $288mln in US IPO - ZAWYA

Oct 25, 2024
pulisher
Oct 25, 2024

GPCR drugmaker Septerna amasses $288M in IPO - BioPharma Dive

Oct 25, 2024
pulisher
Oct 24, 2024

Goldman-backed drug developer Septerna raises $288 mln in US IPO - Reuters

Oct 24, 2024
pulisher
Oct 24, 2024

Septerna Prices Upsized Initial Public Offering - The Manila Times

Oct 24, 2024
pulisher
Oct 24, 2024

SEPNSepterna, Inc. Latest Stock News & Market Updates - StockTitan

Oct 24, 2024
pulisher
Oct 24, 2024

TSX Smallcap Index (TXTW) QuotePress Release - The Globe and Mail

Oct 24, 2024
pulisher
Oct 24, 2024

S&P Midcap 400 (IDX) QuotePress Release - The Globe and Mail

Oct 24, 2024
pulisher
Oct 24, 2024

Yorvipath-finders? Septerna, others forge on in hypothyroidism - BioWorld Online

Oct 24, 2024
pulisher
Oct 24, 2024

Goldman-backed drug developer Septerna targets $743 million valuation in upsized US IPO - MSN

Oct 24, 2024
pulisher
Oct 24, 2024

Septerna Files for 15.28M Share IPO at $18/sh By Investing.com - Investing.com Canada

Oct 24, 2024
pulisher
Oct 24, 2024

Goldman-backed drug developer Septerna targets $743 mln valuation in upsized US IPO - XM

Oct 24, 2024
pulisher
Oct 24, 2024

7 Recent and Upcoming IPOs in 2024 - MSN

Oct 24, 2024
pulisher
Oct 23, 2024

TSX 60 Carbon Price Risk 2030 Adj Index (TXCP) QuotePress Release - The Globe and Mail

Oct 23, 2024
pulisher
Oct 23, 2024

TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail

Oct 23, 2024
pulisher
Oct 22, 2024

Septerna proposes terms for upsized $175M IPO (Pending:SEPN) - Seeking Alpha

Oct 22, 2024
pulisher
Oct 22, 2024

Septerna Readies $175 Million IPO Plan For Endocrine And Immune Disease Treatments (Pending:SEPN) - Seeking Alpha

Oct 22, 2024
pulisher
Oct 21, 2024

TSX 60 ESG Index (TSXE) QuotePress Release - The Globe and Mail

Oct 21, 2024
pulisher
Oct 21, 2024

Goodwin Steers Biotech Firm Septerna's Plans For $175M IPO - Law360

Oct 21, 2024
pulisher
Oct 21, 2024

Biotech Septerna aims to raise up to $186 million in US IPO - WKZO

Oct 21, 2024
pulisher
Oct 21, 2024

Goldman-backed biotech Septerna targets $628 mln valuation in US IPO - Reuters

Oct 21, 2024
pulisher
Oct 21, 2024

Goldman-backed biotech Septerna targets $628 million valuation in US IPO - MSN

Oct 21, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):